---
category: market-operations
circular_id: 6df8bced362db5bc
date: '2026-01-02'
description: BSE has scheduled a mock trading session for Commodity Derivatives segment
  on January 03, 2026 to enable members to test trading platforms and fulfill regulatory
  requirements.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={BF4BB623-7395-4762-96EB-DC586BC48EB5}&noticeno=20260102-6&dt=01/02/2026&icount=6&totcount=7&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine mock trading session for testing purposes with no real trading
  obligations or market impact
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260102-6&attachedId=
processing:
  attempts: 1
  content_hash: 259d8124bf3438b9
  processed_at: '2026-01-02T06:38:07.635031'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-01-02T06:02:15+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={BF4BB623-7395-4762-96EB-DC586BC48EB5}&noticeno=20260102-6&dt=01/02/2026&icount=6&totcount=7&flag=0
severity: low
source: bse
stocks: []
tags:
- mock-trading
- commodity-derivatives
- testing
- uat
- trading-platform
- bolt-tws
title: Mock Trading on Saturday, January 03, 2026 for Commodity Derivatives Segment
---

## Summary

BSE has scheduled a mock trading session for the Commodity Derivatives segment on Saturday, January 03, 2026. This session allows trading members to test their trading platforms, systems, and applications in various market conditions including exceptional scenarios. Members can alternatively use the UAT environment to fulfill regulatory requirements under SEBI circular SEBI/HO/MRD1/DSAP/CIR/P/2020/234 dated November 24, 2020. No actual trades, margins, or settlement obligations will arise from this mock session.

## Key Points

- Mock trading session scheduled for Commodity Derivatives segment on January 03, 2026
- Members can choose between Mock Trading Session or UAT environment for regulatory compliance
- Log-in window: 10:15 AM to 11:00 AM
- Continuous trading: 11:00 AM to 03:30 PM
- No new BOLT TWS release for this session
- Trading members using third-party platforms or in-house systems via IML/ETI APIs can test functionalities
- Testing scenarios include risk-reduction mode, trading halt, and exceptional market conditions
- No margin, pay-in, pay-out obligations or rights/liabilities created from mock trades
- Feedback must be submitted by 4:30 PM on the same day

## Regulatory Changes

No regulatory changes introduced. This circular facilitates compliance with existing SEBI requirements under circular SEBI/HO/MRD1/DSAP/CIR/P/2020/234 dated November 24, 2020 regarding testing of trading and risk management software. Members should also refer to Exchange Notice No 20201201-22 dated December 1, 2020.

## Compliance Requirements

- Members must participate in either Mock Trading Session or UAT environment to fulfill regulatory testing requirements
- Trading members using third-party or in-house trading systems should actively test their platforms during the session
- Members are required to provide feedback on the mock trading session by 4:30 PM on January 03, 2026
- Active participation in mock trading sessions is encouraged

## Important Dates

- **January 03, 2026**: Mock Trading Session
  - Log-in: 10:15 AM - 11:00 AM
  - Continuous Trading: 11:00 AM - 03:30 PM
  - Feedback Deadline: 4:30 PM

## Impact Assessment

**Market Impact**: None. This is a mock trading session with no real market transactions or settlement obligations.

**Operational Impact**: Low. Provides opportunity for members to test and validate their trading systems, ensuring operational readiness. Members using third-party platforms or proprietary systems can verify functionality in simulated exceptional market conditions, reducing potential operational risks in actual trading.

**Member Impact**: Optional participation, allowing flexibility to choose between mock trading or UAT environment for regulatory compliance testing.